{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T08:08:23Z","timestamp":1770538103283,"version":"3.49.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"DOI":"10.1186\/s13256-025-05268-1","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T14:53:12Z","timestamp":1747752792000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Bounce effect or local recurrence after low-dose-rate brachytherapy of the prostate? When prostate-specific membrane antigen positron emission tomography\u2013computed tomography is false positive: a case report"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-9657-0167","authenticated-orcid":false,"given":"Tamas","family":"Rozsos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel S.","family":"Engeler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Peter","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Schwab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"issue":"8","key":"5268_CR1","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1158\/1055-9965.EPI-10-0437","volume":"19","author":"A Jemal","year":"2010","unstructured":"Jemal A, Center MM, DeSantis C, Ward EM. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev. 2010;19(8):1893\u2013907.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"5268_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0360-3016(01)01601-7","volume":"51","author":"PD Grimm","year":"2001","unstructured":"Grimm PD, Blasko JC, Sylvester JE, et al. 10-year biochemical (prostatespecific antigen) control of prostate cancer with 125I brachytherapy. Int J Radiat Oncol Biol Phys. 2001;51:31\u201340.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"5268_CR3","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s40001-023-01140-4","volume":"28","author":"Z Liang","year":"2023","unstructured":"Liang Z, Yuliang C, Zhu M, Zhou Y, Wu X, Li H, Fan B, Zhou Z, Yan W. The direct prognosis comparison of 125I low-dose-rate brachytherapy versus laparoscopic radical prostatectomy for patients with intermediate-risk prostate cancer. Eur J Med Res. 2023;28(1):181. https:\/\/doi.org\/10.1186\/s40001-023-01140-4.","journal-title":"Eur J Med Res"},{"key":"5268_CR4","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.ijrobp.2005.07.960","volume":"64","author":"JP Ciezki","year":"2006","unstructured":"Ciezki JP, Reddy CA, Garcia J, Angermeier K, Ulchaker J, Ma-hadevan A, Chehade N, Altman A, Klein EA. PSA kinetics after prostate brachytherapy: das PSA-Bounce-Ph\u00e4nomen und seine Auswirkungen auf die PSA-Verdopplungszeit. Int J Radiat Oncol Biol Phys. 2006;64:512\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5268_CR5","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.ijrobp.2007.03.031","volume":"69","author":"J Crook","year":"2007","unstructured":"Crook J, Gillan C, Yeung I, Austen L, McLean M, Lockwood G. PSA kinetics and PSA bounce following permanent seed prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2007;69:426\u201333.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"5268_CR6","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.ijrobp.2010.02.021","volume":"80","author":"M Caloglu","year":"2011","unstructured":"Caloglu M, Ciezki JP, Reddy CA, Angermeier K, Ulchaker J, Chehade N, Altman A, Magi-Galuzzi C, Klein EA. PSA bounce and biochemical failure after brachytherapy for prostate cancer: a study of 820 patients with a minimum of 3 years of follow-up. Int J Radiat Oncol Biol Phys. 2011;80(3):735\u201341. https:\/\/doi.org\/10.1016\/j.ijrobp.2010.02.021.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5268_CR7","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s00066-015-0860-0","volume":"191","author":"D Engeler","year":"2015","unstructured":"Engeler D, Schwab C, Th\u00f6ni A, et al. PSA bounce after 125I-brachytherapy for prostate cancer as a favorable prognosticator. Strahlenther Onkol. 2015;191:787\u201391. https:\/\/doi.org\/10.1007\/s00066-015-0860-0.","journal-title":"Strahlenther Onkol"},{"key":"5268_CR8","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/S0360-3016(03)00627-8","volume":"57","author":"MA Kollmeier","year":"2003","unstructured":"Kollmeier MA, Stock RG, Stone N. Biochemical outcomes after prostate brachytherapy with 5-year minimal follow-up: importance of patient selection and implant quality. Int J Radiat Oncol Biol Phys. 2003;57:645\u201353.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5268_CR9","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.eururo.2007.01.015","volume":"51","author":"MN Simmons","year":"2007","unstructured":"Simmons MN, Stephenson AJ, Klein EA. Natural history of biochemical recurrence after radical prostatectomy: risk assessment for secondary therapy. Eur Urol. 2007;51:1175\u201384.","journal-title":"Eur Urol"},{"key":"5268_CR10","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.urology.2005.02.026","volume":"66","author":"CJ Rosser","year":"2005","unstructured":"Rosser CJ, Kamat AM, Wang X, Do K-A, Sanchez-Ortiz RF, Kuban DA, Lee AK, Cheung R, Chichakli R, Pisters LL. Is patient age a factor in the occurrence of prostate-specific antigen bounce phenomenon after external beam radiotherapy for prostate cancer? Urologie. 2005;66:327\u201331.","journal-title":"Urologie"},{"key":"5268_CR11","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1471-2490-12-28","volume":"12","author":"N Tanaka","year":"2012","unstructured":"Tanaka N, Asakawa I, Fujimoto K, Anai S, Hirayama A, Hasega-wa M, Konishi N, Hirao Y. Minimal percentage of dose received by 90 % of the urethra (% UD90) is the most significant predictor of PSA bounce in patients who underwent low-dose-rate brachytherapy (LDR-brachytherapy) for prostate cancer. BMC Urol. 2012;12:28.","journal-title":"BMC Urol"},{"key":"5268_CR12","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/j.1442-2042.2012.03120.x","volume":"20","author":"M Gazta\u00f1aga","year":"2013","unstructured":"Gazta\u00f1aga M, Crook J. Interpreting a rising prostate-specific antigen after brachytherapy for prostate cancer. Int J Urol. 2013;20:142\u20137.","journal-title":"Int J Urol"},{"issue":"2","key":"5268_CR13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.4103\/ijnm.ijnm_113_23","volume":"39","author":"S Ghosh","year":"2024","unstructured":"Ghosh S, Agrawal A, Choudhury S, Purandare NC, Rangarajan V. A case series depicting PSMA expression in nonmalignant lesions. Indian J Nucl Med. 2024;39(2):129\u201334. https:\/\/doi.org\/10.4103\/ijnm.ijnm_113_23.","journal-title":"Indian J Nucl Med"},{"issue":"11","key":"5268_CR14","doi-asserted-by":"publisher","first-page":"E620","DOI":"10.5489\/cuaj.7257","volume":"15","author":"VP Pedro","year":"2021","unstructured":"Pedro VP, Sistani G, Rachinsky I, Zukotynski K, Bauman G, Liu W. Case\u2014prostate-specific antigen bounce: a pitfall in prostate-specific membrane antigen positron emission tomography\/computed tomography interpretation. Can Urol Assoc J. 2021;15(11):E620\u20131. https:\/\/doi.org\/10.5489\/cuaj.7257.","journal-title":"Can Urol Assoc J"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-025-05268-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-025-05268-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-025-05268-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T14:53:13Z","timestamp":1747752793000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-025-05268-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5268"],"URL":"https:\/\/doi.org\/10.1186\/s13256-025-05268-1","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,20]]},"assertion":[{"value":"21 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the journal editor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"242"}}